ŷAV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

FDA's Regulation of OTC Drug Products: 2-day In-Person Seminar

13 - 14 February 2014, Houston, United States


Introduction
The U.S. Food and Drug Administration's ("FDA”) is responsible for the regulation and oversight of the U.S. OTC drug market. Congress has granted FDA regulatory authority over the formulation, manufacturing, labeling, marketing and promotion; and import / export of OCT drug products into the U.S. Under this current regulatory regime, there are 3 pathways that a company may follow to enter the OTC drug market including (a) following an appropriate Drug Monograph; (b) with an Agency approved New Drug Application ("NDA”); or (c) via the currently popular Rx-to-OTC Switch Process.

Useful links

Venue
Houston, TX (Venue to be announced shortly)

Houston, TX (Venue to be announced shortly), Houston, United States

Organised by
ComplianceOnline
Contact information
Mr Referral
2600 E. Bayshore Road, Palo Alto, 94303, United States of America
+1-650-620-3915
Contact us by email

Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*